<DOC>
	<DOCNO>NCT00002248</DOCNO>
	<brief_summary>PRIMARY : To assess effect bovine anti-Cryptosporidium immunoglobulin ( BACI ) volume diarrhea due Cryptosporidium parvum AIDS patient protract Cryptosporidium enteritis . SECONDARY : To assess change stool consistency frequency , body weight , safety patient population .</brief_summary>
	<brief_title>A Randomized , Multicenter , Double-Blind , Parallel-Group , Placebo-Controlled Trial Efficacy Safety Bovine Anti-Cryptosporidium Immunoglobulin ( BACI ) Treatment Cryptosporidium Enteritis AIDS Patients</brief_title>
	<detailed_description>Forty patient randomize receive either BACI placebo ( bovine colostrum non-immunized cattle ) 1 week . The double-blind portion study follow open-label phase 40 patient receive BACI 1 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Enteritis</mesh_term>
	<mesh_term>Cryptosporidiosis</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Antidiarrheal compound ( dose remain stable ) . Zidovudine ( AZT ) , dideoxyinosine ( ddI ) , dideoxycytidine ( ddC ) , alternative HIV therapy ( provide dose stable least 4 week prior study entry ) . Patients must : AIDS . Cryptosporidium parvum enteritis . Chronic diarrhea . Life expectancy least 4 week . Ability tolerate food mouth . Ability take histamine H2receptor antagonist famotidine ( Pepcid ) . Prior Medication : Allowed : Antidiarrheal compound ( provide dose remain stable 7 day prior study entry ) . Zidovudine ( AZT ) , dideoxyinosine ( ddI ) , dideoxycytidine ( ddC ) , alternative HIV therapy ( provide dose remained stable least 4 week prior study entry ) . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Concurrent unresolved clinical infection enteric pathogen C. parvum ( e.g. , rotavirus , Salmonella , Shigella , Campylobacter , Giardia , C. difficile toxin , Yersinia , amebiasis , MAI , CMV , Microsporida ) determine history routine microbiology screening . Other acute infection concurrent immediately lifethreatening medical crisis cryptosporidiosis . Grossly bloody diarrhea . Known allergy milk milk product ( lactose intolerance ) . Prior Medication : Excluded : Other experimental therapy ( e.g. , macrolide antibiotic , paromomycin ) within 30 day prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 1993</verification_date>
	<keyword>Antidiarrheals</keyword>
	<keyword>Cryptosporidiosis</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Cryptosporidium</keyword>
	<keyword>Immunization , Passive</keyword>
</DOC>